Stonepine Capital Management, LLC 13D and 13G filings for Exagen Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:35 pm Sale |
2023-12-31 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 669,684 3.900% |
-184,358 (-21.59%) |
Filing |
| 2023-02-13 10:58 am Sale |
2022-12-31 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 854,042 5.200% |
-4,525 (-0.53%) |
Filing |
| 2022-02-11 7:26 pm Purchase |
2021-12-31 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 858,567 5.300% |
25,030 (+3.00%) |
Filing |
| 2021-12-23 5:33 pm Purchase |
2021-12-20 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 833,537 5.200% |
833,537 (New Position) |
Filing |